The Hippo transducers YAP/TAZ have been shown to play positive, as well as negative, roles in Wnt signaling, but the underlying mechanisms remain unclear. Here, we provide biochemical, functional, and genetic evidence that YAP and TAZ are integral components of the b-catenin destruction complex that serves as cytoplasmic sink for YAP/TAZ. In Wnt-ON cells, YAP/TAZ are physically dislodged from the destruction complex, allowing their nuclear accumulation and activation of Wnt/YAP/TAZdependent biological effects. YAP/TAZ are required for intestinal crypt overgrowth induced by APC deficiency and for crypt regeneration ex vivo. In Wnt-OFF cells, YAP/TAZ are essential for b-TrCP recruitment to the complex and b-catenin inactivation. In Wnt-ON cells, release of YAP/TAZ from the complex is instrumental for Wnt/b-catenin signaling. In line, the b-catenin-dependent maintenance of ES cells in an undifferentiated state is sustained by loss of YAP/ TAZ. This work reveals an unprecedented signaling framework relevant for organ size control, regeneration, and tumor suppression.
INTRODUCTION
Organ growth, tissue regeneration, and tissue replenishment are remarkable processes requiring the concerted activation and restriction of distinct gene-expression programs. How this is achieved by just a handful of signaling cascades is a central question in cell biology. Wnt growth factors play prominent and pleiotropic roles in cell-cell communication, including control of cell fate, proliferation, and stem cell maintenance. A main effector of Wnt signaling is nuclear b-catenin, which regulates the transcription of Wnt target genes by binding to TCF/ Lef transcription factors (Clevers, 2006) . The core of the Wnt pathway is the regulation of b-catenin by a cytoplasmic destruction complex consisting of a central scaffold protein, Axin, that interacts with other factors, such as adenomatous polyposis coli (APC), glycogen synthase kinase-3 (GSK3) and casein kinase 1 (CK1). In the absence of Wnt signaling, the destruction complex efficiently captures cytosolic b-catenin, leading to its phosphorylation by GSK3 and degradation by the b-TrCP ubiquitin ligase. Wnt causes functional inactivation of the destruction complex, with ensuing escape of b-catenin from degradation, resulting into b-catenin accumulation and nuclear entry (Clevers, 2006; Taelman et al., 2010) . The mechanisms by which Wnt inhibits the destruction complex are only partially understood, but recent work indicated that a key step regulated by Wnt is the dissociation of b-TrCP from the complex (Li et al., 2012) . How this step takes place remains unknown.
Independent of these findings, a large body of work has identified YAP and TAZ as pivotal regulators of cell proliferation and ''stemness,'' particularly during organ growth, regeneration, and tumorigenesis . YAP and TAZ are closely related proteins, well known for being nuclear effectors of the Hippo signaling cascade and of mechanical cues (Pan, 2010) .
The overlap between the biological processes governed by YAP/TAZ and Wnt/b-catenin hints that these factors do not work in isolation and may influence each other's activity. In fact, we recently reported a direct biochemical connection: phosphorylated b-catenin promotes TAZ degradation by serving as presenting factor for TAZ to b-TrCP (Azzolin et al., 2012) . By controlling b-catenin stability, Wnt also induces TAZ stabilization and TAZ nuclear entry in a manner independent of Hippo signaling (Azzolin et al., 2012) . By comparison, YAP stability is unaffected by Wnt, and yet, during our subsequent investigations, we found that Wnt signaling also regulates YAP by promoting its nuclear accumulation (as described in the Results section below). These data clearly hinted to the existence of unknown mechanisms by which YAP/TAZ are integrated with the Wnt pathway.
While we studied TAZ regulation by b-catenin, others looked in reciprocal direction and found that Hippo signaling regulates b-catenin but also that YAP/TAZ inhibits Wnt/b-catenin signaling (Heallen et al., 2011; Imajo et al., 2012; Varelas et al., 2010) . For example, genetic knockout of Hippo pathway components in the heart causes concomitant nuclear accumulations of YAP/TAZ and b-catenin, with b-catenin being genetically required downstream of Hippo for organ overgrowth (Heallen et al., 2011) .
How to make sense of these disparate observations? Upon reflection, we realized that all the available evidence could be explained by a simple scenario in which cytoplasmic YAP/TAZ are integral factors of the destruction complex. In this hypothesis, cells without Wnt would, at once, sequester YAP/TAZ to the destruction complex and use them to degrade b-catenin. Wnt stimulation would then eliminate, or inhibit, cytoplasmic YAP/TAZ, causing b-catenin stabilization, as well as YAP/TAZ nuclear accumulation. Here, we have validated this hypothesis at the biochemical, functional, and genetic levels.
RESULTS
YAP/TAZ Are Transcriptionally Inactivated by Sequestration in the Destruction Complex HEK293 cells carry a functional destruction complex. We sought to determine whether YAP/TAZ are constituents of the destruction complex. Axin1 serves as scaffold for all the other known components of the destruction complex, and, owing to its very low abundance, it also represents a rate-limiting factor for complex activity (Li et al., 2012) . We thus probed the endogenous protein composition of the destruction complex in Wnt OFF cells by carrying out immunoprecipitations for endogenous Axin1. Associated proteins were detected by western blotting. This analysis revealed that Axin1 not only bound established elements of the destruction complex (such as GSK3b, b-catenin and b-TrCP) but, remarkably, also strongly associated to endogenous YAP and TAZ ( Figure 1A ). To further confirm YAP/TAZ association to the destruction complex, we carried out immunoprecipitations for endogenous YAP/TAZ from extracts of control or Axin1/2-depleted HEK293 cells. As shown in Figure 1B , YAP and TAZ associate with endogenous Axin1, b-catenin, GSK3, and b-TrCP. Axin1/2 knockdown abolishes YAP/TAZ interaction with b-catenin, GSK3, and b-TrCP, demonstrating that these proteins are part of the same Axin-based protein complexes. The interaction of Axin1 with YAP/TAZ was confirmed with epitope-tagged proteins ( Figure S1B [available online] and data not shown) and occurs independently from the WW domain of YAP ( Figure S1C ). Moreover, the binding between Axin1 and YAP/TAZ appears direct, as it could be recapitulated in vitro using recombinant proteins ( Figure 1C ). Taken together, the data support the view that, in the Wnt OFF condition, YAP/TAZ associated to the destruction complex via interaction with Axin.
What is the relevance of these biochemical interactions for YAP/TAZ function? A hallmark of YAP/TAZ regulation is inhibition of their transcriptional responses through cytoplasmic sequestration. The molecular nature of the cytoplasmic anchors for YAP/TAZ is incompletely understood. For example, phosphorylation of YAP S127 by the Hippo kinase LATS creates a binding consensus for 14-3-3 proteins that are thought to contribute to retain YAP/TAZ in the cytoplasm (Pan, 2010) . This model is, however, not entirely coherent with some recent experimental observations suggesting that YAP phosphorylation is not the major determinant of YAP subcellular localization (Barry et al., 2013; Dupont et al., 2011) ; this suggests the existence of other, yet unknown, mechanisms for YAP/TAZ sequestration in the cytoplasm. In light of the biochemical interactions shown in Figures 1A-1C , we hypothesized that the destruction complex might indeed represent a cytoplasmic anchor for YAP/TAZ (see scheme in Figure 1D ). To test this hypothesis, we carried out Axin1/2 or APC knockdowns and found that this led to a remarkable nuclear accumulation of YAP and TAZ (Figures 1E and S1D) with YAP/TAZ-dependent induction of their transcriptional target CTGF ( Figures 1F, S1E , and S1F). Thus, YAP/TAZ incorporation in the destruction complex favors YAP/ TAZ cytoplasmic sequestration in Wnt-OFF cells.
Wnt Releases YAP/TAZ from the Complex
The destruction complex is at the centerpiece of Wnt pathway regulation, and Wnt signals through inactivation of the destruction complex (Clevers, 2006) . We thus monitored the effect of purified Wnt3A ligand on the subcellular localization of endogenous YAP by immunofluorescence in various cell types (HEK293, ST-2 mesenchymal stem cells, and P19 embryonic carcinoma cells). YAP was mostly cytoplasmic in confluent, untreated cells (Figures 2A and 2B and data not shown) but markedly relocalized in the nucleus after Wnt treatment. This occurred in absence of any effect on YAP protein stabilization ( Figure S2A and data not shown). As expected from our previous report (Azzolin et al., 2012) , TAZ protein was stabilized by Wnt signaling ( Figure S2A ) and, similarly to YAP, TAZ was also relocalized in the nucleus by treatment with Wnt3A ( Figure S2B ). Wnt-induced YAP/TAZ nuclear localization was paralleled by transcriptional activation of the synthetic TEAD reporter (8xGTIIC-Lux) and of the direct YAP/TAZ target genes Cyr61 and Ankrd1 ( Figures  2C, 2D , S2C, and S2D). Of note, YAP/TAZ nuclear accumulation and activation of the TEAD reporter could be detected as early as 30 min after Wnt stimulation, a timing comparable to first detectable induction of the TCF/b-catenin reporter TOP-FLASH (Figure 2E and data not shown).
The above results raise questions on how Wnt signaling impacts YAP/TAZ subcellular localization. It is well known that the destruction complex is recruited to Wnt-activated Fz-LRP6 receptors through Axin/LRP6 interactions (Clevers, 2006) . This prompted us to investigate the effects of Wnt3A stimulation on the interaction between Axin1 and YAP/TAZ. Confirming prior reports (Li et al., 2012; Willert et al., 1999) , after Wnt treatments (t = 0.5, 2, and 4 hr), Axin1 was recruited to LRP6 without causing any modifications in complex composition when we considered the canonical components of the Wnt cascade (GSK3b, b-catenin, and Dishevelled; Figure 2F and data not shown). Strikingly, however, we found that Wnt stimulation changes the molecular composition of the complex in relation to YAP/TAZ; their association with Axin1 rapidly decreases and becomes undetectable after 30 min (TAZ) or at 2 hr (YAP) from Wnt3A addition (Figure 2F) . Consistent results were obtained by immunoprecipitation of Axin1 from lysates of Wnt-treated P19 cells ( Figure S2F ).
Intriguingly, we noticed that the progressive dissociation of YAP/TAZ from Axin paralleled the increased association of Axin1 to LRP6 ( Figure 2F ). These results are compatible with a scenario in which the binding of YAP/TAZ to Axin1 is outcompeted by LRP6, causing YAP/TAZ to be released from the complex ( Figure 2G ). To test this hypothesis, we carried out structure-function studies by GST pull-down assays and assayed distinct C-terminal deletions of Axin1 for ability to interact with recombinant YAP. As schematized in Figure 2H , YAP binds to Axin1 in the same domain that Axin1 uses to dock LRP6 (Mao et al., 2001 ). This conclusion was corroborated by coimmunoprecipitation experiments of HEK293 cell lysates transfected with Flag-YAP and Myc-tagged Axin1 deletion constructs ( Figure S2H ).
If, in Wnt-ON cells, LRP6 releases YAP/TAZ from the destruction complex by displacing them from Axin1, then experimentally raising the doses of LRP6 should titrate Axin1 away from interacting with YAP/TAZ. To test this prediction, HEK293 were transfected with a fixed amount of Axin1 and YAP expression plasmids, together with increasing doses of plasmids encoding for LRP6 ( Figure 2I ). Lysates were immunoprecipitated with anti-Axin antibodies and coprecipitating YAP and LRP6 detected by western blotting. As shown in Figure 2I , YAP is robustly coimmunoprecipitated with Axin1 in the absence of LRP6 (lane 2). In contrast, increasing levels of LRP6 progressively dislodge YAP from Axin1 ( Figure 2I, lanes 3-5) . In line, transfected LRP6 dose-dependently induces the 8xGTIIC-Lux reporter in a YAP/TAZ-dependent manner in both HEK293 and P19 cells ( Figures 2J and S2J) ; moreover, LRP6 overexpression in stably transfected MII cells also turns on the YAP/TAZ endogenous targets Axl, CTGF, Cyr61, and Ankrd1 ( Figure S2K ). We conclude from this set of experiments that, in Wnt OFF cells, the destruction complex is a cytoplasmic sink for YAP/TAZ and that Wnt treatment dislodges YAP/TAZ from the destruction Figure 2G for a scheme).
A Genetic Link between YAP/TAZ and Intestinal Crypt Growth Driven by Wnt Signaling Next, we sought to determine the biological relevance of YAP/ TAZ regulation by the Wnt destruction complex. The intestinal epithelium has been extensively used as model to study Wntdriven tissue homeostasis and regeneration (Clevers, 2006) . Wnt signaling is active on all crypt cells-including intestinal stem cells devoted to normal replenishment of the intestinal tissue-but inactive in villi. Moreover, Wnt signaling has been shown to be instrumental for the in vitro regeneration of cryptlike structures, or crypt organoids, and for epithelial repair in vivo (Ashton et al., 2010; Cordero and Sansom, 2012; de Lau et al., 2011) . Crucially, the destruction complex component APC is the main intestinal tumor suppressor, being inactivated in the large majority of hereditary and sporadic forms of human colorectal cancers (Clevers, 2006) . In mouse models bearing conditional Apc fl/fl alleles, acute activation of the Wnt cascade in the intestinal epithelium causes massive hyperplasia with perturbed differentiation (Sansom et al., 2004) . With this background in mind, we first monitored the expression of endogenous YAP and TAZ by western blotting in dissected crypts and villi. As shown in Figure 3A , both YAP and TAZ are specifically expressed in the crypt compartment (compare lanes 1 and 2); this most likely reflects a posttranscriptional regulation, as we could not detect any differences in mRNA levels between crypts and villi ( Figure S3A ). These results are consistent with a recent report on YAP immunolocalization in the stem cells of the crypt base (Barry et al., 2013) . By comparison, we found that TAZ protein has a broader expression in the nuclei of all crypt cells, with the exception of Paneth cells (Figures S3B and S3C) . Thus, YAP/TAZ nuclear localization in a large fraction of crypt cells is at least consistent with their proposed regulation by endogenous Wnt signals. In line with this conclusion, YAP and TAZ proteins become ectopically stabilized in villi after intestinal-specific knockout of APC (i.e., after tamoxifen treatment of Villin-CreER T2 ; Apc fl/fl mice; Figure 3A , compare lanes 2 and 4). To genetically address the relevance of YAP/TAZ as downstream effectors of Wnt signaling in the mouse small intestine, we compared the effect of acute activation of the pathway induced by APC inactivation in the absence or presence of concomitant genetic ablation of both YAP and TAZ. For this, we generated combined APC, TAZ, and YAP conditional alleles under the control of Figures 3B and 3C ). This was reflected by a rescue of survival, as all the triple mutant mice were still alive and not showing any sign of aberrant crypt hyperplasia after 3 weeks, the endpoint of our experiment (Figures 3B and 3C) . We confirmed that our tamoxifen-induced recombination protocol produced APC and YAP/TAZ mutant crypts by genomic PCR on dissected crypts ( Figure S3F ). Importantly, the b-catenin targets LEF-1 and CD44 remained expressed at elevated levels and ectopically throughout the crypt-villus axis in triple mutant mice ( Figure 3A , compare lanes 3 and 4 with lanes 5 and 6), indicating that ablation of YAP/TAZ does not modify ectopic b-catenin activity induced by the APC mutation. Single depletion of YAP or TAZ was not sufficient to oppose APC inactivation, as APC/YAP or APC/TAZ mutant mice died only few days after those carrying the sole APC inactivation and with the typical intestinal phenotype associated to APC deficiency (data not shown). Individual and double deficiency of YAP and TAZ has little consequences on proliferation of crypt cells and, more generally, on intestinal architecture, suggesting that YAP/TAZ are largely dispensable for intestinal homeostasis (data not shown). The results thus suggest a scenario in which YAP/TAZ transcriptional effects are required for a segment of Wnt responses, such as those caused by Wnt hyperactivation following loss of the destruction complex (see Discussion). The processes that drive hyperplasia in the context of APC deficiency are considered highly analogous to those driving intestinal regeneration after damage (Cordero and Sansom, 2012; Ashton et al., 2010) . With this in mind, we sought to assess the combined relevance of YAP and TAZ for Wnt-dependent responses related to crypt regeneration. For this, we focused on the growth of explanted intestinal crypts into budding organoids, as this represents a well-defined experimental system that requires Wnt signaling and is reminiscent of in vivo regeneration (de Lau et al., 2011 ) and then seeded in Matrigel with a cocktails of supplements, including the Wnt-agonist R-Spondin, which is essential for crypt maintenance and growth (Sato et al., 2009) . Control explants formed organoids in the presence or absence of tamoxifen. Remarkably, tamoxifen-induced combined deletion of YAP/TAZ blocked crypt growth and led to the demise of the mutant crypts, revealing the essential role (H) Panels show the summary of pull-down experiments using full-length YAP and the indicated C-terminal deletion constructs of Axin1, progressively deleting the Dishevelled (Dix), LRP5/6 (LRP), b-catenin (bcat), and GSK3 (GSK)-binding domains, as depicted on the left. of YAP/TAZ in these processes ( Figures 3D and 3E ). This phenotype is reminiscent of combined knockout of the R-Spondin receptors LGR4/5 (de Lau et al., 2011) and reinforces the notion that YAP/TAZ are required for a relevant set of Wnt responses. Of note, individual knockout of TAZ or YAP remains largely compatible with organoid formation, indicating a functional redundancy between these factors ( Figure S3I ).
In the Complex, YAP/TAZ Recruits b-TrCP for b-Catenin Degradation Data presented so far provide strong biochemical and biological evidence that the destruction complex is a cytoplasmic sink for YAP/TAZ. We next decided to change point of view and asked the following question: does YAP/TAZ incorporation affect the most established function of the destruction complex, that is, b-catenin inhibition in Wnt OFF cells? The cytoplasmic pool of b-catenin is constantly degraded through recruitment of the E3 ubiquitin ligase b-TrCP in the destruction complex (Clevers, 2006; Li et al., 2012) . To determine the role of YAP/TAZ in these processes, we carried out knockdowns of YAP/TAZ in HEK293 with independent pairs of siRNAs. Lysates from these cells (Figure S4) were immunoprecipitated with anti-Axin1 antibodies and analyzed by western blotting. As shown in Figure 4A , depletion of YAP/TAZ has no effect on the interaction between Axin1, GSK3, or b-catenin but dramatically impeded b-TrCP association with the complex. Together, this indicates that b-catenin phosphorylation is by itself insufficient for b-TrCP binding, as YAP/TAZ are required for docking b-TrCP to the destruction complex (Figure 4B) . Notably, depletion of YAP/TAZ phenocopies Axin1/2 knockdown or Wnt3A stimulation, leading to a robust and b-catenin-dependent activation of the TOP-FLASH reporter (Figure 4C ). That said, b-catenin inhibition by YAP/TAZ still requires the well-documented b-catenin phosphorylation by GSK3, as a version of b-catenin mutated in its GSK3 sites escapes YAP/ TAZ control ( Figure 4D ). Collectively, the data indicate that the control of b-catenin in Wnt OFF cells is mediated by the convergence of two mechanisms: phosphorylation of b-catenin by GSK3 and b-TrCP docking to the destruction complex via YAP/TAZ ( Figure 4B ).
By Releasing YAP/TAZ, Wnt Blocks the Recruitment of b-TrCP to the Complex
The results also link to how Wnt inhibits the destruction complex. We investigated the composition of the Axin1 complex in Wnt ON cells and found that Wnt stimulation macroscopically inhibits b-TrCP recognition. This cannot be explained by reduced b-catenin phosphorylation: within the complex, the levels of the unphosphorylated b-catenin are actually reduced, indicating that GSK3 remains active on bound b-catenin ( Figure 4E ). These results are consistent with a recent paper by Clevers and colleagues (Li et al., 2012 ) that reported similar observations. However, how b-TrCP fails to be recruited to the destruction complex in Wnt ON cells is unknown. We noticed that, after addition of Wnt, b-TrCP dissociation from Axin1 occurred concomitantly to YAP/TAZ dissociation ( Figure 4E ). Because YAP/TAZ are essential for b-TrCP association to the complex in Wnt OFF cells ( Figure 4A ), the data suggest that Wnt/LRP6 impedes b-TrCP recognition simply by displacing YAP and TAZ from Axin. If so, raising YAP protein levels should allow the destruction complex to ''resist'' inhibition by Wnt/LRP6 signaling. To test this, we expressed increasing levels of wild-type YAP in HEK293 cells and monitored b-catenin/TCF-dependent activation with the TOP-FLASH reporter induced by cotransfected LRP6 or by Wnt treatment. As shown in Figures 5A and 5B, gain-of-YAP effectively inhibits canonical Wnt signaling in a concentration-dependent manner. Consistent results were obtained by measuring the expression of the b-catenin endogenous target Axin2 ( Figures  S5B and S5C ). As control, the same doses of YAP were largely ineffective in cells in which b-catenin activation was triggered by Axin1/2 knockdown ( Figure 5C ) or in APC mutant colorectal cancer cells SW480 ( Figure S5D ), results that are consistent with YAP operating at the level of the destruction complex.
We then sought to demonstrate that the functional inhibition of Wnt/b-catenin signaling by YAP is underlined by a sustained association of YAP to the destruction complex. For this, HEK293 cells were transfected with limiting amounts of Axin1 and LRP6 expression vectors in the presence of increasing amounts of YAP. As shown in Figure 5D , Axin1 immunoprecipitation indeed demonstrated that LRP6/Axin1 complex formation is first weakened and then lost at increasing doses of YAP; in line, YAP binding to Axin1 is inversely correlated to LRP6/Axin1 association ( Figure 5D ). Next, we analyzed how sustained YAP levels affect the composition of the endogenous destruction complex in Wnt-ON cells. Immunoprecipitation of endogenous Axin1 from YAP-expressing and Wnt3A-treated cells revealed that overexpressed YAP sustained b-TrCP association ( Figure 5E ). As such, YAP effectively sustains a ''Wnt-OFF-like''/b-TrCP-bound complex composition opposing the effect of Wnt stimulation.
Cytoplasmic, but Not Nuclear, YAP/TAZ Are b-Catenin Inhibitors: Role in Mouse ES Cells The data presented so far strongly suggest that cytoplasmic YAP/TAZ are integral components of the destruction complex. The corollary of this conclusion is that any YAP/TAZ regulatory input that diverts YAP/TAZ to the nucleus away from the destruction complex would phenocopy, prime, or sustain Wnt/b-catenin signaling; vice versa, any YAP/TAZ regulation that would favor cytoplasmic retention of YAP/TAZ would also favor the activity of the destruction complex and inhibit Wnt/b-catenin signaling. To provide a proof of principle of this notion, we carried out immunohistochemical stainings of the small intestine for the proliferation marker Ki-67 of mice with the indicated genotypes at day 3 or 21 after tamoxifen injection. two sets of experiments. First, we demonstrated that LRP6-mediated activation of the TOP-FLASH reporter is inhibited by wild-type YAP (a prevalently cytoplasmic protein, data not shown), but not by a version of YAP forced to the nucleus by carrying an exogenous nuclear localization signal (NLS) ( Figure 5F ). Second, we considered a main mechanism by which YAP/TAZ are normally retained in the nucleus, that is, inactivation of the Hippo pathway leading to nuclear YAP/TAZ associated with TEAD (Pan, 2010) . This can be mimicked by expression of YAP-5SA or TAZ-4SA variants, bearing mutations that do not allow LATS phosphorylation, and are typically localized to the nucleus (Pan, 2010 Figure 5G , compare lanes 5 and 6).
We next aimed to demonstrate the relevance of YAP/TAZ for b-catenin inhibition on relevant biological effects controlled by b-catenin/TCF beyond the monitoring of b-catenin activity with the TOP-FLASH reporter. In pondering these experiments, we excluded Wnt-dependent phenotypes requiring both YAP/TAZ and b-catenin/TCF transcriptional programs; we reasoned that, in these cases, the consequences of losing nuclear YAP/TAZ functions would be dominant, preventing any assessment of the role of cytoplasmic YAP/TAZ as b-catenin inhibitors. Thus, we focused on mouse embryonic stem (ES) cells, as these can be propagated in an undifferentiated and pluripotent state when cultured in the fully defined ''2i'' medium consisting of serum-free medium supplemented with two inhibitors targeting MEK and GSK3 (''PD'': PD0325901 and ''CH'': CHIR99021, respectively) (Ying et al., 2008) . In these conditions ( Figure 6A ), b-catenin-dependent transcriptional responses are required for ES cell maintenance: genetic ablation of b-catenin or omission of the GSK3 inhibitor from the medium (i.e., ''PD-only'' medium, corresponding to GSK3-ON and nuclear b-catenin-OFF) both lead to loss of self-renewal and activation of differentiation, as previously reported (Wray et al., 2011) .
Importantly, through an unrelated research line in our laboratory, we had discovered that quantitative YAP/TAZ depletion by independent siRNA pairs is inconsequential for ES cell propagation in the 2i medium ( Figure S6A and see below) . For example, depletion of YAP and TAZ has no effect on the Rex1-GFPd2 ES cells ( Figure S6B ), which express an unstable form of GFP driven by endogenous Rex1 locus, a gene expressed only by undifferentiated ES cells (Martello et al., 2012) . Thus, the maintenance of ES cells in undifferentiated/self-renewing state in the 2i media requires b-catenin activity, but not nuclear YAP and TAZ responses.
These results defined a straightforward experimental setup in which YAP/TAZ nuclear responses are ostensibly irrelevant downstream of Wnt, allowing us to focus on YAP/TAZ cytoplasmic functions. If YAP/TAZ inhibit b-catenin at the level of the destruction complex, then loss of YAP/TAZ should phenocopy GSK3 inhibition and compensate for the absence of the GSK3 inhibitor in the ES cell medium. As shown in Figures 6B  and S6B , depletion of YAP and TAZ with two independent pairs Figure S6 and Table S1. of siRNAs is in fact sufficient to rescue the formation of domeshaped colonies of ES cells, AP positivity, and maintenance of the reporter REX1-GFP in the otherwise differentiating PD-only medium. These biological results are paralleled by the rescue of endogenous b-catenin stabilization to levels comparable to cells cultured with the GSK3 inhibitor ( Figure 6C ), a result consistent with YAP/TAZ being relevant for the function of the destruction complex. To validate genetically that b-catenin mediates the effect of YAP/TAZ depletion, we compared the effects of YAP/ TAZ inactivation on b-catenin fl/À (heterozygous control) versus b-catenin null ES cells cultured in absence of GSK3 inhibitor. In line with our prediction, YAP/TAZ knockdown partially rescued AP staining in control, but not in b-catenin knockout cells ( Figure 6D) .
Finally, we asked to what extent the transcriptional program activated by Wnt signaling in ES cells is under negative regulation by YAP/TAZ. For this, we compared the Affimetrix gene-expression profiles of ES cells transfected with control or anti-YAP/TAZ siRNAs and cultured either in 2i or with the PD inhibitor alone. GSK3 inhibition is likely to have pleiotropic transcriptional effects; because of this, gene sets upregulated by the GSK3 inhibitor in control-siRNA-treated samples were filtered according to previously identified TCF3 targets in ES cells (Yi et al., 2011; see Experimental Procedures) . These bioinformatic analyses revealed 157 TCF/b-catenin targets confidently downregulated in our ES cells after removal of the GSK3 inhibitor (Table S1). Of these, a remarkably large fraction (139 genes, 88%) is rescued by concomitant depletion of YAP/TAZ ( Figure 6E ). This set includes two of the best-characterized targets of b-catenin/ TCF targets in ES cells, Axin2 and Esrrb (Martello et al., 2012; Yi et al., 2011) . In fact, RT-PCR analysis confirmed that expres- sion of these genes is potently downregulated in cells cultured in the absence of the GSK3 inhibitor and that is rescued by YAP/TAZ knockdown ( Figure 6F ). Based on these data, we conclude that YAP/ TAZ are global inhibitors of b-catenin/TCF transcriptional responses in mouse ES cells.
DISCUSSION

A Framework for Wnt Signal Transduction
The findings presented here reveal an unexpectedly deep integration between YAP/TAZ and the Wnt pathway (see Figure 7 for a model) . We show that, in the absence of Wnt, YAP and TAZ are components of the destruction complex to which YAP/TAZ associate by binding to Axin1. We propose that the destruction complex serves as cytoplasmic anchor and functional sink for YAP/TAZ. Treatment with Wnt ligands or loss of destruction complex components (i.e., depletion of Axin or APC) causes rapid release of YAP/TAZ from the complex, leading to their nuclear relocalization and activation of YAP/TAZ/TEAD-dependent transcription. How does Wnt achieve this? Wnt ligands are known to induce clustering of LRP6, in turn triggering functional inactivation of the destruction complex via association of LRP6 to Axin (Mao et al., 2001) . We now found that YAP/TAZ and LRP6 compete for the same domain of Axin to the extent that the association of Axin to YAP/TAZ is incompatible with Axin associating to LRP6. Thus, Axin/YAP/TAZ complexes dominate in Wnt-OFF cells, whereas Axin/LRP6 complexes dominate in Wnt-ON cells. Wnt signaling physically dislodges YAP/TAZ from the destruction complex, causing their nuclear accumulation and activation of target gene-expression.
After focusing on the destruction complex as cytoplasmic sink for YAP/TAZ, we investigated the role of YAP/TAZ for the most established function of the destruction complex, namely, b-catenin inactivation. Here, we provide evidence that, in the Wnt OFF scenario, YAP/TAZ incorporation in the destruction complex is essential for b-TrCP recruitment to the complex. Indeed, depletion of YAP/TAZ-or forcing them in the nucleus (i.e., away from the cytoplasmic complex)-renders the complex invisible to b-TrCP. As such, depletion of YAP/TAZ blocks the activity of the destruction complex against b-catenin, mimicking Wnt stimulation. In other words, in Wnt ON cells, nuclear YAP/TAZ represent a branch of the Wnt transcriptional effects, whereas in the Wnt OFF condition, cytoplasmic YAP/TAZ are effective inhibitors of Wnt/b-catenin responses. These two functions of YAP/TAZ stem from being integral to the destruction complex but rely on distinct cellular states (i.e., Wnt ON versus OFF) and distinct YAP/TAZ localizations (i.e., nuclear versus cytoplasmic). In fact, the apparent duality of YAP/TAZ represents an elegant mechanism by which cells make sure that Wnt signaling causes a coherent and concomitant activation of YAP/TAZ and b-catenin: YAP/TAZ nuclear localization facilitates the escape of b-catenin from the destruction complex. Conversely, YAP/TAZ nuclear exit goes hand in hand with activation of YAP/TAZ anti-b-catenin effects.
We previously showed that the protein stability of TAZ, but not of YAP, is regulated by phospho-b-catenin (Azzolin et al., 2012) . The present paper significantly extends those findings: on the one hand, we show that, beyond protein stability, nuclearcytoplasmic shuttling of YAP and TAZ is regulated by their sequestration in the b-catenin destruction complex. On the other hand, we found that the association of TAZ with b-catenin also requires an intact destruction complex, given that this association is inhibited by Axin1/2 knockdown. Collectively, the data suggest a unified model for YAP/TAZ regulation by the destruction complex in Wnt OFF cells: YAP and TAZ are sequestered by the destruction complex, where they play an essential role for phospho-b-catenin degradation by recruiting b-TrCP (Figure 7 ). In the reciprocal direction, the destruction complex brings about the phospho-b-catenin/TAZ/b-TrCP association that leads to TAZ degradation ( Figure 1B (Lian et al., 2010 ); yet, our data do not support this conclusion in cells cultured in fully defined 2i medium.
In the second scenario, nuclear YAP/TAZ transcriptional responses, rather than b-catenin/TCF, may serve as primary mediators of the effects of Wnt signaling. A paradigm for such scenario is the Wnt-dependent differentiation of mesenchymal stem cells into bone. Although mouse genetics indicate a role for canonical Wnt signaling in bone differentiation, it has been reported that b-catenin deletion fails to recapitulate the phenotype of LRP5 mutants, indicating the involvement of factors other than b-catenin downstream of Wnt (Baron and Kneissel, 2013) . We previously showed that TAZ mediates this phenotype (Azzolin et al., 2012) . Moreover, we could extend such a requirement for YAP during Wnt-induced bone differentiation of ST-2 mesenchymal progenitor cells (L.A. and S.P., unpublished data).
In the third scenario, both YAP/TAZ-and b-catenin/TCFdependent gene expression programs are essential to attain the full panel of Wnt-regulated biological effects. We have genetically validated this scenario in the biology of intestinal crypts for which the role of b-catenin/TCF is already well established (Clevers, 2006) . APC inactivation in conditional knockout mice is a paradigm model system to study the effects of Wnt signaling on the expansion of progenitor cells (Sansom et al., 2004) . Here, we show that YAP/TAZ are remarkably essential for this phenotype: APC/YAP/TAZ triple knockouts display ostensibly normal crypts and villi, overcoming the rapid demise of mice with the sole APC deficiency. Intriguingly, this rescue occurs in spite of an underlying aberrant activation of Wnt/b-catenin-dependent transcription, as visualized in triple mutants by ectopic LEF1 or CD44 expression throughout the crypt-villus axis, to levels comparable to those seen in APC knockouts. This reinforces the notion that b-catenin and YAP/TAZ nuclear programs must necessarily complement each other in the context of intestinal crypt overgrowth induced by the inactivation of the destruction complex. Development of intestinal ''organoids'' in vitro is known to require the Wnt-agonist R-Spondin (de Lau et al., 2011) . Here, we genetically validated the requirement of YAP/TAZ for intestinal crypt outgrowth ex vivo and found that YAP and TAZ are essential for the expansion and survival of explanted intestinal crypts, phenocopying the effect of LGR4/5 knockouts (i.e., the R-spondin receptors).
In light of these results, it is worth discussing the apparent lack of YAP/TAZ relevance for normal intestinal homeostasis. It is possible that b-catenin and the YAP/TAZ transcriptional programs may carry out an effective ''division of labor'' downstream of Wnt signaling, with b-catenin/TCF controlling normal homeostasis and YAP/TAZ playing a more dominant role in conditions characterized by intense intestinal proliferation, such as during APC deficiency, tumorigenesis, regeneration, or ex vivo crypt regrowth (reviewed in Cordero and Sansom, 2012) . In line with this interpretation, YAP has been shown to be essential in some regenerative contexts, such as intestinal recovery after inflammatory damage (Cai et al., 2010) .
Cross-Regulations
We further note that nuclear YAP/TAZ may trigger ''Wnt'' signaling-perhaps even in the absence of Wnt ligands or by cooperating with subeffective amounts of surrounding Wnts. For example, a general bias in considering intestinal crypt biology is the assumption that Wnt ligands are the upstream inducers of b-catenin signaling. However, evidence in this direction is surprisingly scant (San Roman et al., 2014) . Notably, nuclear YAP/TAZ accumulation can be induced by tissue architectural cues and mechanotransduction (Aragona et al., 2013; Dupont et al., 2011) . Intriguingly, computational modeling studies predicted that the crypt's own 3D architecture and mechanical forces are the key ingredients for crypt biology and self-organizing properties (Buske et al., 2012) ; in fact, biomechanical parameters-such as the curvature of the basal membrane and dynamic cell shape changes at the crypt bottommay trigger YAP/TAZ nuclear localization along with a b-catenin response (Figure 7) . Clearly, further work is required to expand on these ideas. Irrespective of the nature of the upstream signals that regulate YAP/TAZ localization, both YAP and TAZ are nuclear in intestinal crypt cells. The lack of phenotype in YAP/ TAZ intestinal knockouts during normal tissue homeostasis suggests that endogenous YAP/TAZ nuclear localization at the bottom of the intestinal crypts may simply represent a mean to remove YAP/TAZ from the cytoplasm to prevent their anti-b-catenin effects. In this view, as much as YAP/TAZ cytoplasmic localization represents an inhibition of their transcriptional responses, their nuclear localization may represent a relief from their antiWnt effects. If, during normal intestinal homeostasis, YAP/TAZ are already inhibited by ''nuclear sequestration'' in crypt cells, this might explain why their genetic ablation is inconsequential for normal physiology. Although speculative, this scenario might explain why overexpression of a cytoplasmic and transcriptionally defective version of YAP can rapidly terminate Wnt signaling, turn off b-catenin/TCF targets, and cause crypt degeneration in transgenic mice (Barry et al., 2013) .
The Hippo pathway is another pillar of YAP/TAZ regulation. In the heart, knockout of the Hippo pathway components Salvador and MST1/2 also turns on nuclear b-catenin localization and activation of Wnt-target genes, including some that are under joined control of b-catenin/TCF and YAP/TAZ/TEAD responsive promoter elements (Heallen et al., 2011) . Crucially, b-catenin is genetically required for heart overgrowth induced by Hippo pathway deficiencies. How can b-catenin escape the strict control of the destruction complex when the Hippo cascade is turned off? The model described in Figure 7 accommodates these findings. Inactivation of the Hippo pathway would facilitate YAP/TAZ nuclear activities, diverting them away from the cytoplasmic destruction complex; as a result, b-catenin is no longer inactivated, with loss of Hippo signaling de facto turning on Wnt signaling. Although there is currently no evidence that the activity of Hippo kinases is patterned in living tissues, YAP/TAZ nuclear versus cytoplasmic localization by the Hippo pathway might modify the thresholds of the Wnt/YAP/TAZ and of the Wnt/b-catenin responses.
Prior to this study, Varelas et al. (2010) suggested that the Hippo pathway might attenuate Wnt/b-catenin signaling and that this correlated with TAZ-mediated regulation of Dvl phosphorylation by CK1. The functional relevance of Dvl phosphorylation in the context of Wnt signaling remains unclear; in any case, Dvl phosphorylation is known to occur independently from the destruction complex (Gonzalez-Sancho et al., 2013) . This suggests that the Dvl regulatory layer may act in Wnt ON cells in parallel to the anti-b-catenin effects of cytoplasmic YAP/TAZ at the level of the destruction complex here described.
Finding that YAP/TAZ inactivation is detrimental for proliferation and self-renewal of cells modified by aberrant, oncogenic Wnt signaling-but not for normal stem cells-has implications in the cancer field. YAP/TAZ activation is frequent in human tumors; our data at least suggest that, in adult organs, YAP/ TAZ may be at the heart of a genetic program of tissue regeneration normally inactive during normal tissue replenishment but locked in an ON state for tumor growth. For example, this may expand cells with stem cells characteristics . In this view, only self-renewal and proliferation of the tumor tissue, but not those of its corresponding normal tissue, would be addicted to YAP/TAZ; as such, YAP/TAZ and its upstream regulators may represent prime targets to develop more effective and less toxic cancer therapies.
EXPERIMENTAL PROCEDURES
Monitoring Wnt Effects on YAP/TAZ For immunofluorescence in HEK293 cells, P19 cells and ST-2 cells were plated at 100% confluency on fibronectin-coated chamberslides (Nunc). After 24 hr, cultured medium was changed to medium containing Wnt3A (R&D, 100 ng/ml). Treatment lasted 8 hr before fixation with PFA 4%. For transfected MII cells, these were plated at 20% confluency and then transfected with siRNAs, and the next day, they were plated at very high density on fibronectin-coated chamberslides; cells were fixed after 48 hr. Immunofluorescence was as described in Cordenonsi et al. (2011) using anti-YAP (H-9 sc-271134; 1:200, blocking in goat serum; monoclonal antibody was from Santa Cruz) and anti-TAZ (560235; 1:100, blocking in BSA; monoclonal antibody was from BD Bioscience).
For the luciferase assay, cells were plated at 25% confluence (day 0) and the next day (day 1) were transfected with DNA. At day 2, cells were washed from DNA-transfection medium and harvested after 24 hr (day 3). For luciferase assays in siRNA-depleted cells, cells were plated at 20% confluence (day 0), and the next day (day 1), they were transfected with the indicated siRNAs for no more than 8 hr before changing medium. At day 2, cells were transfected with DNA, at day 3, the medium was changed, and cells were harvested at day 4. Where indicated, cells were treated with recombinant Wnt3A (R&D; final concentration 100 ng/ml) for 8 hr before harvesting, unless otherwise specified (i.e., Figure 2E ). Each sample was transfected in duplicate, and each experiment was repeated at least three times independently. siRNA sequences are listed in Table S2 .
